These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31410774)

  • 21. Role of dihydrotestosterone in post-stroke peripheral immunosuppression after cerebral ischemia.
    Dziennis S; Akiyoshi K; Subramanian S; Offner H; Hurn PD
    Brain Behav Immun; 2011 May; 25(4):685-95. PubMed ID: 21262338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xuesaitong May Protect Against Ischemic Stroke by Modulating Microglial Phenotypes and Inhibiting Neuronal Cell Apoptosis via the STAT3 Signaling Pathway.
    Li F; Zhao H; Han Z; Wang R; Tao Z; Fan Z; Zhang S; Li G; Chen Z; Luo Y
    CNS Neurol Disord Drug Targets; 2019; 18(2):115-123. PubMed ID: 30426907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D
    Evans MA; Kim HA; Ling YH; Uong S; Vinh A; De Silva TM; Arumugam TV; Clarkson AN; Zosky GR; Drummond GR; Broughton BRS; Sobey CG
    Neuromolecular Med; 2018 Mar; 20(1):147-159. PubMed ID: 29476479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A
    Hawkins KE; DeMars KM; Alexander JC; de Leon LG; Pacheco SC; Graves C; Yang C; McCrea AO; Frankowski JC; Garrett TJ; Febo M; Candelario-Jalil E
    Brain Behav; 2017 May; 7(5):e00688. PubMed ID: 28523230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Therapeutic Potential of Anti-TLR4-Antibody MTS510 in Experimental Stroke and Significance of Different Routes of Application.
    Andresen L; Theodorou K; Grünewald S; Czech-Zechmeister B; Könnecke B; Lühder F; Trendelenburg G
    PLoS One; 2016; 11(2):e0148428. PubMed ID: 26849209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis.
    Ooi JD; Li M; Kourkoutzelos K; Yagita H; Azuma M; Holdsworth SR; Kitching AR
    Nephrology (Carlton); 2015 Dec; 20(12):892-8. PubMed ID: 26043977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Essential role of program death 1-ligand 1 in regulatory T-cell-afforded protection against blood-brain barrier damage after stroke.
    Li P; Mao L; Liu X; Gan Y; Zheng J; Thomson AW; Gao Y; Chen J; Hu X
    Stroke; 2014 Mar; 45(3):857-64. PubMed ID: 24496394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depletion of CD4 T cells provides therapeutic benefits in aged mice after ischemic stroke.
    Harris NM; Roy-O'Reilly M; Ritzel RM; Holmes A; Sansing LH; O'Keefe LM; McCullough LD; Chauhan A
    Exp Neurol; 2020 Apr; 326():113202. PubMed ID: 31954116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells.
    Frenkel D; Huang Z; Maron R; Koldzic DN; Hancock WW; Moskowitz MA; Weiner HL
    J Immunol; 2003 Dec; 171(12):6549-55. PubMed ID: 14662856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesencephalic astrocyte-derived neurotrophic factor restores blood-brain barrier integrity of aged mice after ischaemic stroke/reperfusion through anti-inflammation via TLR4/MyD88/NF-κB pathway.
    Han D; Li F; Zhang H; Ji C; Shu Q; Wang C; Ni H; Zhu Y; Wang S
    J Drug Target; 2022 Apr; 30(4):430-441. PubMed ID: 34747270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotection by the cannabidiol aminoquinone VCE-004.8 in experimental ischemic stroke in mice.
    Lavayen BP; Yang C; Larochelle J; Liu L; Tishko RJ; de Oliveira ACP; Muñoz E; Candelario-Jalil E
    Neurochem Int; 2023 May; 165():105508. PubMed ID: 36863495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of macrophage migration inhibitory factor in mice does not affect hallmarks of the inflammatory/immune response during the first week after stroke.
    Inácio AR; Bucala R; Deierborg T
    J Neuroinflammation; 2011 Jun; 8():75. PubMed ID: 21714902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice.
    Dziennis S; Mader S; Akiyoshi K; Ren X; Ayala P; Burrows GG; Vandenbark AA; Herson PS; Hurn PD; Offner HA
    Metab Brain Dis; 2011 Jun; 26(2):123-33. PubMed ID: 21472429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blocking TLR2 in vivo protects against accumulation of inflammatory cells and neuronal injury in experimental stroke.
    Ziegler G; Freyer D; Harhausen D; Khojasteh U; Nietfeld W; Trendelenburg G
    J Cereb Blood Flow Metab; 2011 Feb; 31(2):757-66. PubMed ID: 20842165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke.
    Bodhankar S; Chen Y; Lapato A; Vandenbark AA; Murphy SJ; Offner H
    Front Cell Neurosci; 2014; 8():228. PubMed ID: 25157219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective role of Na
    Song S; Wang S; Pigott VM; Jiang T; Foley LM; Mishra A; Nayak R; Zhu W; Begum G; Shi Y; Carney KE; Hitchens TK; Shull GE; Sun D
    Glia; 2018 Nov; 66(11):2279-2298. PubMed ID: 30043461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the sigma-1 receptor agonist 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)-piperazine dihydro-chloride on inflammation after stroke.
    Ruscher K; Inácio AR; Valind K; Rowshan Ravan A; Kuric E; Wieloch T
    PLoS One; 2012; 7(9):e45118. PubMed ID: 23028794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PDL1 Fusion Protein Protects Against Experimental Cerebral Malaria via Repressing Over-Reactive CD8
    Wang J; Li Y; Shen Y; Liang J; Li Y; Huang Y; Liu X; Jiang D; Yang S; Zhao Y; Yang K
    Front Immunol; 2018; 9():3157. PubMed ID: 30693001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rosiglitazone ameliorates tissue plasminogen activator-induced brain hemorrhage after stroke.
    Li Y; Zhu ZY; Lu BW; Huang TT; Zhang YM; Zhou NY; Xuan W; Chen ZA; Wen DX; Yu WF; Li PY
    CNS Neurosci Ther; 2019 Dec; 25(12):1343-1352. PubMed ID: 31756041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.